Scinai Immunotherapeutics Quote - SCNI

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.40

Bid

3.30

Ask

9.15

Volume

5,552

3.35 Day's Range 3.4999

0.00 52 Week Range 0.00

Market Cap

2.847M

Previous Close

3.37

Open

3.36

Last Trade

3.3

Last Trade Time

Financial Volume

US$ 18,961

VWAP

3.4152

Average Volume (3m)

Shares Outstanding

837,310

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

Net Profit

-6.5M

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic ... BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Coml Physical, Biologcl Resh

Website

www.biondvax.com

Headquarters

Jerusalem, Jerusalem, Isr

Founded

2012

Scinai Immunotherapeutics Ltd is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SCNI. The last closing price for Scinai Immunotherapeutics was US$3.37. Over the last year, Scinai Immunotherapeutics shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Scinai Immunotherapeutics currently has 837,310 shares outstanding. The market capitalization of Scinai Immunotherapeutics is US$2.82 million.

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc. PR Newswire JERUSALEM, Dec. 16, 2024 JERUSALEM, Dec. 16, 2024 /PRNewswire/ -- Scinai...

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board PR...

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board PR Newswire JERUSALEM, Nov. 27, 2024...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million PR Newswire JERUSALEM, Nov. 22...

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024 PR Newswire JERUSALEM, Oct. 31, 2024 JERUSALEM, Oct. 31, 2024 /PRNewswire/...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies

Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies PR Newswire JERUSALEM, Israel, Sept. 16, 2024 JERUSALEM, Israel...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

SCNI - Frequently Asked Questions (FAQ)

What is the current Scinai Immunotherapeutics share price?

The current share price of Scinai Immunotherapeutics is US$ 3.40

How many Scinai Immunotherapeutics shares are in issue?

Scinai Immunotherapeutics has 837,310 shares in issue

What is the market cap of Scinai Immunotherapeutics?

The market capitalisation of Scinai Immunotherapeutics is USD 2.82M

What is the 1 year trading range for Scinai Immunotherapeutics share price?

Scinai Immunotherapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the reporting currency for Scinai Immunotherapeutics?

Scinai Immunotherapeutics reports financial results in USD

What is the latest annual turnover for Scinai Immunotherapeutics?

The latest annual turnover of Scinai Immunotherapeutics is USD 9k

What is the latest annual profit for Scinai Immunotherapeutics?

The latest annual profit of Scinai Immunotherapeutics is USD -6.5M

What is the registered address of Scinai Immunotherapeutics?

The registered address for Scinai Immunotherapeutics is JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, JERUSALEM, 7403618

What is the Scinai Immunotherapeutics website address?

The website address for Scinai Immunotherapeutics is www.biondvax.com

Which industry sector does Scinai Immunotherapeutics operate in?

Scinai Immunotherapeutics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	120.01M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	76.64M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	33.95M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.61k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	120.4M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	277.63M

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Scinai Immunotherapeutics Ltd (SCNI) Share Price

Scinai Immunotherapeutics Ltd (SCNI)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Scinai Immunotherapeutics Ltd

Ask ADVFN Intelligence (AI)

SCNI Latest News

SCNI - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR